Skip to main content

Blogs

What Goes Wrong with the Immune System in PMR?

Polymyalgia rheumatica (PMR) is a common inflammatory rheumatic disease. The exact trigger for PMR onset remains unknown. However, immunology studies and clinical trials with biological DMARDs now shed light on the immune pathways involved in PMR.

Frailty in PMR: Why do I need to care?

It is important to clarify that frailty is not a synonym of age (chronological age). Although there are only a few studies studying the impact of frailty in PMR, frailty is a relevant issue due to several important factors.

IL-6 Inhibitors in PMR: Give early or late?

It's exciting to be able to have this conversation because it's only in the past year that we have an approved non-corticosteroid therapy for PMR that's been shown to be effective in a well done clinical trial.

PMR: glad or bad tidings?

Please don’t tell your patient that PMR “typically” lasts two years. According to real-world data from the UK, one in four patients with PMR is prescribed steroids by their primary care physician for over four years. But nobody tells them this at the start, and that causes big problems later on.

Why aren’t we preventing RA yet?

Ever since the seminal studies demonstrating a prolonged preclinical period for seropositive RA, which have been replicated in multiple cohorts around the world using both retrospective and prospective study designs, the rheumatology community has been tantalized by the prospect of preventing the onset of inflammatory joint disease in seropositive individuals exhibiting no clinically detectable synovitis. So why can’t we prevent RA yet?

An Opportunity to Say Yes

Often, I am asked why I get to do all the fun stuff in rheumatology like blogging, traveling, meeting and interviewing interesting people, and collaborating in cool projects. How do I get those opportunities? Why am I involved in so many things? The answer: because I say, “Yes!”

No is a complete sentence

No is a complete sentence. For context, I am a "yes" person, and I always have been.

Giving Good Care in Diversity takes Time

Dr. Yvonne Sherrer and second-year fellow Dr. Corin Agoris discuss a case where extended time led to improved patient outcomes.

My Life in the Gray Zone

For someone who grew up in a family of engineers, where logic and definitive answers were absolute, I live comfortably in the gray zone of uncertainty.  

The Benefits of Networking

Networking provides the framework for an exchange of ideas and new opportunities that can actually open doors.

Best of 2022: The Sacred Bond

Patients and their family for years have been inviting me to their dinners, picnics, baptisms, anniversaries, and funerals. I always felt somewhat awkward when asked to participate in a patient’s life outside of my office or the hospital setting and usually will decline politely. I tell myself I should not blur the lines between patient care and friendship. I broke this rule recently.

The Sacred Bond

Patients and their family for years have been inviting me to their dinners, picnics, baptisms, anniversaries, and funerals. I always felt somewhat awkward when asked to participate in a patient’s life outside of my office or the hospital setting and usually will decline politely. I tell myself I should not blur the lines between patient care and friendship. I broke this rule recently.
×